Feed/Investors/André Hoffmann

André Hoffmann

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on 2 rounds in the feed, most often in Healthtech.

Individual investorRounds from 2024-10-09 to 2026-09-23

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$200M

across 2 rounds

LATEST ROUND

Series C · $140M · 2026-09-23

CO-INVESTORS

named beside it

Rounds

[ 2 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Basecamp Research A London AI company that trains frontier models on its proprietary Trillion Gene Atlas to design therapeutics, starting with in vivo cell therapies	Series C Verified against 4 of 62 sources	$140M	2026-09-23	[ PART ]
Basecamp Research A London AI company that trains frontier models on its proprietary Trillion Gene Atlas to design therapeutics, starting with in vivo cell therapies	Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$60M	2024-10-09	[ PART ]